Logos Global Management LP - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.

Quarter-by-quarter ownership
Logos Global Management LP ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,068,000
-54.6%
300,000
-14.3%
1.74%
-53.3%
Q1 2022$28,777,000
+292.3%
350,000
+600.0%
3.73%
+393.5%
Q4 2021$7,335,000
-33.2%
50,0000.0%0.76%
-19.7%
Q4 2020$10,982,000
+79.2%
50,000
-37.3%
0.94%
-59.6%
Q1 2020$6,127,000
-92.8%
79,699
-88.0%
2.33%
-88.9%
Q4 2019$85,520,000663,66021.08%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$688,784,00067.42%
Avoro Capital Advisors LLC 4,535,000$996,067,00017.15%
Darwin Global Management, Ltd. 260,876$57,299,00015.99%
Boxer Capital, LLC 1,765,560$387,788,00012.46%
Perceptive Advisors 3,693,516$811,244,0008.71%
Consonance Capital Management LP 330,000$72,481,0006.77%
EcoR1 Capital, LLC 464,298$101,978,0005.48%
Fairmount Funds Management LLC 60,500$13,288,0004.75%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 67,400$14,804,0004.04%
RTW INVESTMENTS, LP 1,054,364$231,581,0003.88%
View complete list of MIRATI THERAPEUTICS INC shareholders